Shopping Cart
- Remove All
Your shopping cart is currently empty
(E/Z)-ZINC09659342
🥰Excellent
Catalog No. T9986Cas No. 591726-26-0
(E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction.
(E/Z)-ZINC09659342
🥰Excellent
Purity: 95.83%
Catalog No. T9986Cas No. 591726-26-0
(E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | 57 € | In Stock | |
| 5 mg | 140 € | In Stock | |
| 10 mg | 221 € | In Stock | |
| 25 mg | 377 € | In Stock | |
| 50 mg | 533 € | In Stock | |
| 100 mg | 718 € | In Stock | |
| 200 mg | 937 € | In Stock | |
| 1 mL x 10 mM (in DMSO) | 154 € | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "(E/Z)-ZINC09659342"
Azathioprine
Cited
BW 57-322
T1237446-86-6
Azathioprine (BW 57-322), an immunosuppressive agent, inhibits purine synthesis and GTP-binding protein Rac1 activation.
- 42 €
Size
QTY
CitedSKLB-163
SKLB163
T261931255099-06-9In house
SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.
- 130 €
Size
QTY
CCG-257081
MRTF/SRF-IN-1, CCG257081, CCG 257081
T307781922098-90-5In house
CCG-257081 (MRTF/SRF-IN-1) is an inhibitor of cardiac myosin-related transcription factor and serum response factor (MRTF/SRF) that acts by inhibiting the Rho/MRTF/SRF pathway.CCG-257081 has shown efficacy in preventing bleomycin-induced fibrosis in several mouse models. CCG-257081 can be used in cancer prevention and fibrosis research.
- 122 €
Size
QTY
Zoledronic Acid Cited
Zometa, Zoledronate, ZOL 446, CGP42446A, CGP 42446
T6739118072-93-8
Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronic Acid (ZOL 446) is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis.
- 30 €
Size
QTY
CitedRhosin hydrochloride
T167451281870-42-5
Rhosin hydrochloride is a specific inhibitor of the RhoA subfamily Rho GTPases and inhibits the RhoA-GEF interaction. Rhosin hydrochloride can significantly induce cell apoptosis without affecting cell cycle progression. [1]
- 153 €
Size
QTY
CCG-203971
CCG203971
T43061443437-74-8
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.
- 45 €
Size
QTY
Z62954982
ZINC08010136
T371131090893-12-1
Z62954982 (ZINC08010136) is a selective inhibitor of Rac1, which stunts the growth and branching of neurons.Z62954982 inhibits Rac1 activation and reduces proliferation, p38 phosphorylation, and IL-6 levels in pulmonary arterioles.
- 30 €
Size
QTY
Digeranyl bisphosphonate
DGBP
T12452878143-03-4In house
Digeranyl bisphosphonate (DGBP) is a potent geranylgeranyl pyrophosphate (GGPP) synthase inhibitor that impedes the geranyl pyrophosphorylation of Rac1 and induces autophagy without causing apoptosis.
- 249 €
Size
QTY
EHop-016 Cited
EHop 016
T24271380432-32-5
EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1 in MDA-MB-231 and MDA-MB-435 cells, equally effective inhibition for Rac3.
- 38 €
Size
QTY
CitedY16
T3553429653-73-6
Y16 is a G protein-coupled Rho GEFs inhibitor that synergizes with Rhosin/G04 to inhibit LARG-RhoA interaction, RhoA activation, and RhoA-mediated signaling. Y16 is also a specific inhibitor of LARG with a Kd of 76 nM.
- 28 €
Size
QTY
EHT 1864 2HCl Cited
T6483754240-09-0
EHT 1864 (EHT 1864 2HCl) is a Rac family GTPase inhibitor that blocks activation by direct binding to Rac1, Rac1b, Rac2, and Rac3 (Kd=40/50/60/250 nM). EHT 1864 inhibits Rac, Ras, and Tiam-induced growth transformation of NIH-3T3 fibroblasts.
- 37 €
Size
QTY
CitedITX3
T15602347323-96-0
ITX3 is a specific, non-toxic, active and selective TrioN RhoGEF inhibitor with IC50 of 76 μM. ITX3 has anticancer effects, inhibits trion mediated GTP exchange on RhoG and Rac1, inhibits NGF-mediated neurite growth in PC12 cells and REF52 fibroblast structure formation induced by trion.
- 33 €
Size
QTY
Select Batch
Purity:95.83%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | (E/Z)-ZINC09659342 is an inhibitor of Lbc-Rho A interaction. |
| Molecular Weight | 440.37 |
| Formula | C23H15F3N2O4 |
| Cas No. | 591726-26-0 |
| Smiles | CC1=NN(C(=O)\C1=C\c1ccc(o1)-c1cccc(c1)C(F)(F)F)c1ccc(cc1)C(O)=O |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
| Solubility Information | DMSO: 6.43 mg/mL (14.6 mM)  | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy (E/Z)-ZINC09659342 | purchase (E/Z)-ZINC09659342 | (E/Z)-ZINC09659342 cost | order (E/Z)-ZINC09659342 | (E/Z)-ZINC09659342 chemical structure | (E/Z)-ZINC09659342 formula | (E/Z)-ZINC09659342 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.